Search Results | MSF Science Portal

Journal Article

|

Commentary

Sprecher A, Cross RW, Marzi A, Martins KA, Wolfe D, et al.

2023-08-19 • Journal of Infectious Diseases

Although there are now approved treatments and vaccines for Ebola virus disease (EVD), the case fatality of EVD remains unacceptably high even when treated with the newly approved therap...

Journal Article

|

Research

Rosenke K, Adjemian J, Munster VJ, Marzi A, Falzarano D, et al.

2016-08-15 • Clinical Infectious Diseases

BACKGROUND
The ongoing Ebola outbreak in West Africa has resulted in 28 646 suspected, probable, and confirmed Ebola virus infections. Nevertheless, malaria remains a large public he...

Journal Article

|

Research

de Wit E, Kramer S, Prescott JB, Rosenke K, Falzarano D, et al.

2016-07-28 • Journal of Infectious Diseases

The development of point-of-care clinical chemistry analyzers has enabled the implementation of these ancillary tests in field laboratories in resource-limited outbreak areas. The Eterna...

Journal Article

|

Research

Grolla A, Jones SM, Fernando L, Strong JE, Stroher U, et al.

2011-05-24 • PLOS Neglected Tropical Diseases

Background: Marburg virus (MARV), a zoonotic pathogen causing severe hemorrhagic fever in man, has emerged in Angola resulting in the largest outbreak of Marburg hemorrhagic fever (MHF) ...

Journal Article

|

Short Report

Nguku PM, Sharif S, Omar A, Nzioka C, Muthoka P, et al.

2007-02-02 • MMWR. Morbidity and mortality weekly report

In mid-December 2006, several unexplained fatalities associated with fever and generalized bleeding were reported to the Kenya Ministry of Health (KMOH) from Garissa District in North Ea...

Journal Article

|

Research

de Wit E, Falzarano D, Onyango C, Rosenke K, Marzi A, et al.

2016-02-01 • Emerging Infectious Diseases

Malaria is a major public health concern in the countries affected by the Ebola virus disease epidemic in West Africa. We determined the feasibility of using molecular malaria diagnostic...

Journal Article

|

Letter

Rosenke K, Adjemian J, Munster VJ, Strong JE, Sprecher A, et al.

2016-12-15 • Clinical Infectious Diseases

Journal Article

|

Research

Cross RW, Bornholdt ZA, Prasad AN, Geisbert JB, Borisevich V, et al.

2020-07-27 • Nature Communications

A replication-competent vesicular stomatitis virus vaccine expressing the Ebola virus (EBOV) glycoprotein (GP) (rVSV-ZEBOV) was successfully used during the 2013-16 EBOV epidemic. Additi...

Journal Article

|

Commentary

Sprecher A, Caluwaerts C, Draper M, Feldmann H, Frey C, et al.

2015-03-27 • Journal of Infectious Diseases

Personal protective equipment (PPE) is an important part of worker protection during filovirus outbreaks. The need to protect against a highly virulent fluid-borne pathogen in the tropic...

Journal Article

|

Review

Feldmann H, Sprecher A, Geisbert TW

2020-05-07 • New England Journal of Medicine

Science Portal

Perspectives on advancing countermeasures for Filovirus disease: Report from a multi-sector meeting

Plasmodium parasitemia associated with increased survival in Ebola virus-infected patients

Clinical chemistry of patients with Ebola in Monrovia, Liberia

The use of a mobile laboratory unit in support of patient management and epidemiological surveillance during the 2005 Marburg outbreak in Angola

Rift Valley fever outbreak--Kenya, November 2006-January 2007

The merits of malaria diagnostics during an Ebola virus disease outbreak

Reply to Colebunders: Is Plasmodium species parasitemia really associated with increased survival in Ebola virus-infected patients?

Prior vaccination with rVSV-ZEBOV does not interfere with but improves efficacy of postexposure antibody treatment

Personal Protective Equipment for Filovirus Epidemics: A Call for Better Evidence

Ebola